LANTHEUS HOLDINGS, INC.
Ownership & governance
Executives 5Directors 10Avg age 66Avg tenure 5.7y
MH
Mary Heino
Chief Executive Officer
Age 66Since 2025-12-31Profile →
+14
Executives5
MH
Mary Heino→
Chief Executive Officer
Age 66Since 2025-12-31
RM
Robert Marshall→
Director of Finance/CFO
Age 60Since 2018-09-20
LD
Ludger Maria Dinkelborg→
Chief Tech/Sci/R&D Officer
Age 64Since 2025-07-31
LH
Lee Anne Howe→
Chief Tech/Sci/R&D Officer
—Since 2015-12-31
JP
Jean-Claude Provost→
Chief Tech/Sci/R&D Officer
Age 62Since 2022-04-03
Board of directors10
SL
Sam Leno→
Director/Board Member
Age 80Since 2012-04-30
MH
Mary Heino→
Chairman
Age 66Since 2024-02-29
JM
Julie McHugh→
Director/Board Member
Age 61Since 2016-12-31
GP
Gary Pruden→
Director/Board Member
Age 64Since 2018-01-31
JT
James Thrall→
Director/Board Member
Age 82Since 2018-01-31
GB
Gérard Ber→
Director/Board Member
Age 68Since 2020-06-18
HM
Heinz Christoph Mäusli→
Director/Board Member
Age 63Since 2020-06-18
MB
Minnie Baylor-Henry→
Director/Board Member
Age 78Since 2022-02-28
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BlackRock Advisors LLC | 11.66 % | 7,593,557 |
| Farallon Capital Management LLC | 8.576 % | 5,583,479 |
| Janus Henderson Investors US LLC | 7.403 % | 4,819,667 |
| Fidelity Management & Research Co. LLC | 7.106 % | 4,626,453 |
| Vanguard Portfolio Management LLC | 4.876 % | 3,174,274 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Jean-Claude Provost | Chief Tech/Sci/R&D Officer | 2022-04-03 | - |
| Lee Anne Howe | Chief Tech/Sci/R&D Officer | 2015-12-31 | - |
| Ludger Maria Dinkelborg | Chief Tech/Sci/R&D Officer | 2025-07-31 | - |
| Mary Heino | Chief Executive Officer | 2025-12-31 | - |
| Mary Heino | Chairman | 2024-02-29 | - |
| Robert Marshall | Director of Finance/CFO | 2018-09-20 | - |
| Gary Pruden | Director/Board Member | 2018-01-31 | - |
| Gérard Ber | Director/Board Member | 2020-06-18 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Lantheus Medical Imaging, Inc. | Medical Specialties |
| Lantheus Medical Imaging, Inc. | Medical Specialties |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 107.74Range 102.5–115Analysts 8
102.5Mean 107.74115
- Strong buy 1
- Buy 2
- Hold 7
Broker actions40 of 95
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Truist Securities | Downgrade | Hold | 102.5 | 2026-08-04 |
| CJS Securities | Downgrade | Market Perform | — | 2026-08-04 |
| William Blair | Downgrade | Market Perform | — | 2026-08-03 |
| TD Cowen | Downgrade | Hold | 102.5 | 2026-08-03 |
| Mizuho | Maintained | Outperform | 115 | 2026-07-29 |
| Truist Securities | Maintained | Buy | 125 | 2026-07-16 |
| Mizuho | Maintained | Outperform | 120 | 2026-07-15 |
| B. Riley Securities | Maintained | Buy | 129 | 2026-07-09 |
| Citizens | Reiterated | Market Outperform | 115 | 2026-06-29 |
| Mizuho | Maintained | Outperform | 115 | 2026-05-27 |
| Truist Securities | Reiterated | Buy | 115 | 2026-05-11 |
| Citizens | Maintained | Market Outperform | 115 | 2026-05-08 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.